Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Lachman, Herbert M., Papolos, Demitri F., Saito, Takuya, Yu, Yue-Min, Szumlanski, Carol L., Weinshilboum, Richard M.·1996·Pharmacogenetics

Cited by (1,001)

Items 601–700 of 1,001

  1. Pharmacogenomics of anticoagulants: steps toward personal dosage
    Ann K. Daly · 2009 · Genome Medicine
  2. Genetic heterogeneity in schizophrenia II: conditional analyses of affected schizophrenia sibling pairs provide evidence for an interaction between markers on chromosome 8p and 14q
    Y.-F. Chiu, John A. McGrath, Mary H. Thornquist, Paula S Wolyniec, Gerald Nestadt, Karen Swartz, Virginia K. Lasseter, K.-Y. Liang, Ann E. Pulver · 2002 · Molecular Psychiatry
  3. The downside of strong emotional memories: How human memory-related genes influence the risk for posttraumatic stress disorder – A selective review
    Sarah Wilker, Thomas R. Elbert, Iris‐Tatjana Kolassa · 2013 · Neurobiology of Learning and Memory
  4. Genetic Differential Sensitivity to Social Environments: Implications for Research
    Mitchell, Colter, McLanahan, Sara, Brooks-Gunn, Jeanne, Garfinkel, Irwin, Hobcraft, John, Notterman, Daniel · 2013 · American Journal of Public Health
  5. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls
    Katrine Verena Wirgenes, Srdjan Djurovic, Kjetil S. Sundet, Ingrid Agartz, Morten Mattingsdal, Lavinia Athanasiu, Ingrid S. Melle, Ole A. Andreassen · 2010 · Schizophrenia Research
  6. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder
    Keun-Ah Anna Cheon, Jin-Yong Jun, Dae-Yeon Cho · 2008 · International Clinical Psychopharmacology
  7. Pharmacogenetics of smoking cessation therapy
    Gustavo Lucena Kortmann, Cristina Jaureguy Dobler, Lisiane Bizarro, Claiton H.D. Bau · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  8. Impact of COMT Val158Met‐polymorphism on appetitive conditioning and amygdala/prefrontal effective connectivity
    Tim Klucken, Onno Kruse, Sina Wehrum‐Osinsky, Juergen Hennig, Jan Schweckendiek, Rudolf M. Stark · 2014 · Human Brain Mapping
  9. Fearfulness, neuroticism/anxiety, and COMT Val158Met in long-term fear conditioning and extinction
    Christian Panitz, Matthias F. J. Sperl, Juergen Hennig, Tim Klucken, Christiane Hermann, Erik Malte Mueller · 2018 · Neurobiology of Learning and Memory
  10. Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
    Marina Šagud, Lucija Tudor, Suzana Uzun, Matea Nikolac Perković, Maja Živković, Marcela Konjevod, Oliver Kozumplik, Bjanka Vuksan Ćusa, Dubravka Švob Štrac, Iva Radoš et al. · 2018 · Frontiers in Pharmacology
  11. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case–control study
    Michael Poyurovsky, Elena Michaelovsky, Amos Frisch, Gabriela Knoll, Ilan Amir, Boris Finkel, Feodor Buniak, Haggai Hermesh, Ronit Weizman · 2005 · Neuroscience Letters
  12. Five Latent Factors Underlying Schizophrenia: Analysis and Relationship to Illnesses in Relatives
    John A. McGrath, Gerald Nestadt, K.-Y. Liang, Virginia K. Lasseter, Paula S Wolyniec, M. Daniele Fallin, Mary H. Thornquist, James R. Luke, A. E. Pulver · 2004 · Schizophrenia Bulletin
  13. Effects of Comt Genotype on Behavioral Symptomatology in the 22q11.2 Deletion Syndrome
    Bearden, Carrie E., Jawad, Abbas F., Lynch, David R., Monterossso, John R., Sokol, Set, McDonald-McGinn, Donna M., Saitta, Sulagna C., Harris, Stacy E., Moss, Edward, Wang, Paul P. et al. · 2005 · Child Neuropsychology
  14. Mild Cognitive Impairment in Parkinson’s Disease: A Review of Current Concepts
    Natalie C. Palavra, Sharon Linda Naismith, Simon J.G. Lewis · 2013 · Neurology Research International
  15. The Role of Genetic Factors in the Development of Hyperhomocysteinemia
    Jürgen Geisel, Ulrich Hübner, Marion Bodis · 2003 · Clinical Chemistry and Laboratory Medicine (CCLM)
  16. Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics
    Ari Illi, Olli Kampman, Sami A. K. Anttila, Markus Roivas, Kari M. Mattila, Terho J. Lehtimäki, Esa V. J. Leinonen · 2003 · European Neuropsychopharmacology
  17. Genetic Variants Associated With Resilience in Human and Animal Studies
    Stephanie Cahill, Tarani Chandola, Reinmar Hager · 2022 · Frontiers in Psychiatry
  18. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women
    Ollin Celeste Martínez‐Ramírez, Rebeca Pérez–Morales, C. Castro · 2012 · The Breast
  19. Can genes for mammographic density inform cancer aetiology?
    Linda E. Kelemen, Thomas A. Sellers, Celine M. Vachon · 2008 · Nature reviews. Cancer
  20. Female Reproductive Factors, Gene Polymorphisms in the Estrogen Metabolism Pathway, and Risk of Lung Cancer in Chinese Women
    Wei Yen Lim, Ying Chen, Khoon-Leong Chuah et al. · 2012 · American Journal of Epidemiology
  21. Interaction of early environment, gender and genes of monoamine neurotransmission in the aetiology of depression in a large population-based Finnish birth cohort
    Emma S Nyman, Sonja Sulkava, Pia Soronen, Jouko Miettunen, Anu Loukola, Virpi Leppä, Matti I. Joukamaa, Pirjo H. Mäki, Marjo‐Riitta Järvelin, Nelson B. Freimer et al. · 2011 · BMJ Open
  22. Gene–gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia
    Veera Manikandan Rajagopal, Anto Praveen Rajkumar, Kuruthukulangara Sebastian Jacob, Molly Jacob · 2017 · Pharmacogenetics and Genomics
  23. Catechol‐<i>O</i>‐methyltransferase gene methylation and substance use in adolescents: the <scp>TRAILS</scp> study
    van der Knaap, L. J., Schaefer, J. M., Franken, I. H. A., Verhulst, F. C., van Oort, F. V. A., Riese, H. · 2014 · Genes, Brain and Behavior
  24. Pharmacogenetics of Opiates in Clinical Practice: the Visible Tip of the Iceberg
    Aline Hajj, Lydia Rabbaa Khabbaz, Jean Laplanche, Katell Peoc’h · 2013 · Pharmacogenomics
  25. Functional characterization of an oxytocin receptor gene variant (rs2268498) previously associated with social cognition by expression analysis in vitro and in human brain biopsy
    Martin Reuter, Christian Montag, Steffen Altmann, Fabian Bendlow, Christian Erich Elger, Peter Kirsch, Albert J. Becker, Susanne Schoch, Matthias Simon, Bernd Weber et al. · 2016 · Social Neuroscience
  26. Emotional Dysfunction in Psychopathology and Neuropathology
    Virginia E. Sturm, Claudia M. Haase, ROBERT WAYNE LEVENSON · 2016 · Elsevier eBooks
  27. Fetal growth interacts with multilocus genetic score reflecting dopamine signaling capacity to predict spontaneous sugar intake in children
    Patrícia Pelufo Silveira, Irina Pokhvisneva, Hélène Gaudreau, Leslie R. Atkinson, Alison S. Fleming, Marla B. Sokolowski, Meir S Steiner, James L. Kennedy, Laurette Dubé, Robert D. Levitan et al. · 2017 · Appetite
  28. Stressful life events, perceived stress, and 12-month course of geriatric depression: Direct effects and moderation by the 5-HTTLPRandCOMTVal158Met polymorphisms
    Anthony S. Zannas, Douglas R. McQuoid, David C. Steffens, George Panagiotis Chrousos, Warren D. Taylor · 2012 · Stress
  29. Catechol‐O‐methyltransferase polymorphism (COMT) in suicide attempters: A possible gender effect on anger traits
    Patrick Baud, Philippe Courtet, Nader Ali Perroud, Fabrice Jollant, Catherine Burési, Alain Malafosse · 2007 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  30. Genetic association studies of performance monitoring and learning from feedback: The role of dopamine and serotonin
    Markus Ullsperger · 2009 · Neuroscience & Biobehavioral Reviews
  31. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia
    Tae‐Won Park · 2002 · European Neuropsychopharmacology
  32. No association between COMT val158met polymorphism and suicidal behavior: meta-analysis and new data
    Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, Teresa Ramón-Frías, Mario Villar-Soto, Sherezada Pool-García, Beatríz Camarena, Alma Delia Genis Mendoza, María Lilia López‐Narváez, Humberto Nicolini · 2011 · BMC Psychiatry
  33. COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems
    Marte Swart, Richard Bruggeman, Frank Larøi, Behrooz Z. Alizadeh, Ido Kema, Rudie Kortekaas, Durk Wiersma, André Aleman · 2010 · NeuroImage
  34. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives
    Zhen Hu, Chuan-Gui Song, Jing-Song Lu · 2007 · Journal of Cancer Research and Clinical Oncology
  35. Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults
    Bernhard M. Meyer, Julia Huemer, Ulrich Rabl, Roland N. Boubela, Klaudius Kalcher, Andreas Berger, Tobias Banaschewski, Gareth J. Barker, Arun L.W. Bokde, Christian Büchel et al. · 2014 · Brain Structure and Function
  36. How Neuroscience and Behavioral Genetics Improve Psychiatric Assessment: Report on a Violent Murder Case
    Davide Rigoni, Silvia Pellegrini, Veronica Mariotti, Arianna Cozza, Andrea Mechelli, Santo Davide Ferrara, Pietro Pietrini, Giuseppe Sartori · 2010 · Frontiers in Behavioral Neuroscience
  37. Genetic Influence of COMT and BDNF Gene Polymorphisms on Resilience in Healthy College Students
    Jee In Kang, Se Joo Kim, Yun Young Song, Kee Namkoong, Suk Kyoon An · 2013 · Neuropsychobiology
  38. TheCOMTandDRD3genes interacted in bipolar I but not bipolar II disorder
    Sheng-Yu Lee, Shiou‐Lan Chen, Shih‐Heng Chen et al. · 2010 · The World Journal of Biological Psychiatry
  39. Polymorphisms in Catechol- O -Methyltransferase Modify Treatment Effects of Aspirin on Risk of Cardiovascular Disease
    Kathryn Tayo Hall, Christopher P. Nelson, Roger B. Davis, Julie E. Buring, Irving Kirsch, Murray A. Mittleman, Joseph Loscalzo, Nilesh J. Samani, Paul M. Ridker, Ted Jack Kaptchuk et al. · 2014 · Arteriosclerosis Thrombosis and Vascular Biology
  40. Dopamine Modulation of the Prefrontal Cortex and Cognitive Function
    Jeremy Keith Seamans, Trevor William Robbins · 2009 · Humana Press eBooks
  41. Limited Associations of Dopamine System Genes With Alcohol Dependence and Related Traits in the Irish Affected Sib Pair Study of Alcohol Dependence (IASPSAD)
    Laura M. Hack, Gursharan Kalsi, Fazil Alıev, Po‐Hsiu Kuo, Carol Arlene Prescott, Diana G. Patterson, Dermot Walsh, Danielle M. Dick, Brien P. Riley, Kenneth S. Kendler · 2010 · Alcoholism Clinical and Experimental Research
  42. Genetics of Lesch's typology of alcoholism
    Jerzy Samochowiec, Jolanta Kucharska–Mazur, Anna Grzywacz, Justyna Pełka-Wysiecka, Monika Mak, Agnieszka Samochowiec, Przemysław Bieńkowski · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  43. Breast Cancer Risk Reduction and Membrane-Bound Catechol O -Methyltransferase Genetic Polymorphisms
    Yuan Ji, Janet E. Olson, Jianping Zhang, Michelle Hildebrandt, Liewei Wang, James N. Ingle, Zachary Fredericksen, Thomas A. Sellers, William Miller, J. Michael Dixon et al. · 2008 · Cancer Research
  44. Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator
    Theresa Swift‐Scanlan, Christopher T. Smith, Sabrina Anne Bardowell, Charlotte A. Boettiger · 2014 · BMC Medical Genomics
  45. Association of catechol-O-methyltransferase (COMT) polymorphism and academic achievement in a Chinese cohort
    Ting‐Kuang Yeh, Chun‐Yen Chang, Chung‐Yi Hu, Ting-Chi Yeh, Ming-Yeh Lin · 2009 · Brain and Cognition
  46. Advances in Uterine Leiomyoma Research: Conference Overview, Summary, and Future Research Recommendations
    Retha R. Newbold, Richard P. DiAugustine, John Ian Risinger, Jeffrey I. Everitt, David K. Walmer, Estella C. Parrott, Darlene Dixon · 2000 · Environmental Health Perspectives
  47. Catechol- O -methyltransferase: variation in enzyme activity and inhibition by entacapone and tolcapone
    Chiara De Santi, P. C. Giulianotti, Andrea Pietrabissa · 1998 · European Journal of Clinical Pharmacology
  48. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives
    Вера Евгеньевна Голимбет, Inga Gritsenko, М. В. Алфимова, И. С. Лебедева, Т. В. Лежейко, Lilia I. Abramova, В. Г. Каледа, Richard P. Ebstein · 2006 · The World Journal of Biological Psychiatry
  49. COMT genotype and response to cognitive remediation in schizophrenia
    Jean‐Pierre Lindenmayer, Anzalee Khan, Herbert M. Lachman, Susan R. McGurk, Abraham Goldring, Amod Thanju, Saurabh Kaushik · 2015 · Schizophrenia Research
  50. Adolescent Cannabis Use, Psychosis and Catechol-O-Methyltransferase Genotype in African Americans and Caucasians
    Joshua T. Kantrowitz, Karen A. Nolan, Srijan Sen · 2009 · Psychiatric Quarterly
  51. Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder
    Ari Illi, Eija Setälä-Soikkeli, Olli Kampman · 2010 · Psychiatry Research
  52. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis
    Young Ho Lee, Jae‐Hoon Kim, Gwan Gyu Song · 2014 · Rheumatology International
  53. Gene–gene interaction between MAOA and COMT in suicidal behavior
    Vincenzo De Luca, Subi Tharmalingam, Tricia Sicard, James L. Kennedy · 2005 · Neuroscience Letters
  54. Assessing genetic polymorphisms using DNA extracted from cells present in saliva samples
    Zsófia Nemoda, Maria Horvat‐Gordon, Christine Fortunato, Emilie K. Beltzer, Jessica L Scholl, Douglas Alan Granger · 2011 · BMC Medical Research Methodology
  55. Genetic Factors Modulating the Response to Stimulant Drugs in Humans
    Amy B. Hart, Harriet de Wit, Abraham A. Palmer · 2011 · Current topics in behavioral neurosciences
  56. Genetic and imaging strategies in obsessive–compulsive disorder: potential implications for treatment development
    D.R. Rosenberg, Gregory L. Hanna · 2000 · Biological Psychiatry
  57. Are catechol-O-methyltransferase gene polymorphisms genetic markers for pain sensitivity after all? – A review and meta-analysis
    Annabel Vetterlein, Merlin Monzel, Martin Reuter · 2023 · Neuroscience & Biobehavioral Reviews
  58. Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers
    Doug-Hyun Han, Keun‐Ho Joe, Chul Na, Young-Sik Lee · 2008 · Psychiatric Genetics
  59. Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females
    Ivo Heitland, J. Leon Kenemans, Ronald S. Oosting, Johanna M.P. Baas, K.B.E. Böcker · 2013 · Behavioural Brain Research
  60. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
    Kim Wolff, Eva-Maria Tsapakis, Carmine Maria Pariante, Robert W Kerwin, Mary L. Forsling, Katherine Jean Aitchison · 2011 · Journal of Psychopharmacology
  61. Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder
    Catherine L. Taylor Clelland, Valérie Drouet, Kelly C. Rilett, Jennifer Smeed, Robert H. Nadrich, Amit Rajparia, Laura L. Read, James D. Clelland · 2016 · Translational Psychiatry
  62. Mouse Liver Nicotinamide N-Methyltransferase:
    Lan Yan, Diane M. Otterness, Timothy L Craddock · 1997 · Biochemical Pharmacology
  63. The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study
    Maryam Omidvar, Lisette Stolk, André Gerardus Uitterlinden, Albert Hofman D, Cornelia M. van Duijn, Henning W. Tiemeier · 2008 · Pharmacogenetics and Genomics
  64. Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response
    Y Ji, Joanna M. Biernacka, K Snyder, M Drews, Linda L. Pelleymounter, C Colby, L Wang, David A. Mrazek, Richard M. Weinshilboum · 2010 · The Pharmacogenomics Journal
  65. Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction
    Fumihiro Sata, Hideto Yamada, Katsuya Suzuki, Yasuaki Saijo, Takashi Yamada, Hisanori Minakami, Reiko Kishi · 2006 · Pharmacogenetics and Genomics
  66. Association of Eating Disorders with Catechol-O-Methyltransferase Gene Functional Polymorphism
    Elżbieta Mikołajczyk, Małgorzata Śmiarowska, Anna Grzywacz · 2006 · Neuropsychobiology
  67. Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks
    Linh C. Dang, James P. O’Neil, William J. Jagust · 2012 · NeuroImage
  68. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia
    Rael D. Strous, Raya Lapidus, Dina Viglin, Moshe Kotler, Herbert M. Lachman · 2005 · Neuroscience Letters
  69. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
    Camila Tanabe Matsuzaka, Denise Maria Christofolini, Vanessa Ota, Ary Gadelha, Arthur de Almeida Berberian, Cristiano de Souza Noto, Diego R. Mazzotti, Letícia Spíndola, Patrícia Natália Silva Moretti, Marı́lia de Arruda Cardoso Smith et al. · 2017 · Brazilian Journal of Psychiatry
  70. Baroreceptor Modulation of the Cardiovascular System, Pain, Consciousness, and Cognition
    Heberto Suárez-Roca, Negmeldeen F. Mamoun, Martin Ingi Sigurdsson, William D. Maixner · 2021 · Comprehensive physiology
  71. A genetic contribution to cooperation: Dopamine-relevant genes are associated with social facilitation
    Nora T. Walter, Sebastian A. Markett, Christian Montag, Martin Reuter · 2010 · Social Neuroscience
  72. The V108M mutation decreases the structural stability of catechol O-methyltransferase
    Karen Rutherford, Edouard Alphandéry, Andrew W. McMillan, Valerie Daggett, Walther Parson · 2008 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  73. Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal Intubation
    Laure Elens, Elisabeth Norman, Maja Matić · 2016 · Therapeutic Drug Monitoring
  74. Catechol-O-methyltransferase (COMT) genotype affects cognitive control during total sleep deprivation
    Brieann C. Satterfield, John M. Hinson, Paul J. Whitney, Michelle A. Schmidt, Jonathan P. Wisor, Hans P. A. Van Dongen · 2017 · Cortex
  75. Catecholamine Metabolism
    Alan A. Bodton, Graeme Eisenhofer · 1997 · Advances in pharmacology
  76. Candidate genes for panic disorder: insight from human and mouse genetic studies
    Mónica Gratacòs, Ignasi Sahún, Xavier Gallego, Alejandro Amador‐Arjona, Xavier Estivill, Mara Dierssen · 2007 · Genes Brain & Behavior
  77. Metabolic Pathways Involved in 2-Methoxyestradiol Synthesis and Their Role in Preeclampsia
    Alejandra Pérez‐Sepúlveda, Pedro P. España-Perrot, Errol R. Norwitz, Sebastian Enrique Illanes · 2013 · Reproductive Sciences
  78. The role of the COMT Val158Met polymorphism in the phenotypic expression of obsessive‐compulsive disorder
    Hilga Katerberg, Daniëlle C. Cath, Damiaan A J P Denys, Peter Heutink, Annemiek Polman, Filip Van Nieuwerburgh, Dieter L. D. Deforce, Zoltán Bochdanovits, Anton J.L.M. van Balkom, Johan A. den Boer · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  79. Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A
    J. Elia, M. Capasso, Zafar Zaheer, F. Lantieri, P. Ambrosini, W. Berrettini, M. Devoto, H. Hakonarson · 2009 · Psychiatric Genetics
  80. Proton Magnetic Resonance Spectroscopy in Alcohol Use Disorders: A Potential New Endophenotype?
    Dieter Johannes Meyerhoff, Timothy C. Durazzo · 2008 · Alcoholism Clinical and Experimental Research
  81. Plasma Homovanillic Acid: A Significant Association with Alcoholism is Independent of a Functional Polymorphism of the Human Catechol-O-Methyltransferase Gene
    Michael D. Köhnke, Gerlinde Wiatr, Werner Kolb, Annette M Köhnke, Sandra Schick, Ulrich C. Lutz, Reinhard Vonthein, Ines Gaertner · 2002 · Neuropsychopharmacology
  82. Catechol‐O‐methyltransferase (COMT) gene variants: Possible association of the Val158Met variant with opiate addiction in hispanic women
    Bronson E. Oosterhuis, K. Steven LaForge, Dmitri Proudnikov, Ann Ho, David A. Nielsen, Robert J. Gianotti, Sandra Barral, Derek Gordon, Suzanne M. Leal, Jürg Ott et al. · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  83. Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura
    Jeong Wook Park, Kwang Soo Lee, Joong‐Seok Kim, Yeong-In Kim, Hae Eun Shin · 2007 · Journal of Clinical Neurology
  84. The COMT val158met Polymorphism Is Associated With Peak BMD in Men
    Mattias Lorentzon, Anna‐Lena Eriksson, Dan Mellström, Claes Ohlsson · 2004 · Journal of Bone and Mineral Research
  85. Genetic abnormalities of chromosome 22 and the development of psychosis
    Nigel M. Williams, Michael John Owen · 2004 · Current Psychiatry Reports
  86. Catechol-O-methyltransferase Val(108/158)Met polymorphism affects fronto-limbic connectivity during emotional processing in bipolar disorder
    Benedetta Vai, Martina Riberto, Sara Poletti, Irene Bollettini, Cristina Lorenzi, Cristina Colombo, Francesco Benedetti · 2017 · European Psychiatry
  87. Molecular and genetic basis of depression
    MADHUMITA ROY, Madhu G. Tapadia, Shobhna Joshi, Biplob Koch · 2014 · Journal of Genetics
  88. The COMT Val158Met polymorphism regulates the effect of a dopamine antagonist on the feedback‐related negativity
    Erik Malte Mueller, Christin Burgdorf, Mira‐Lynn Chavanon, Desirée Schweiger, Jürgen Hennig, Jan Wacker, Gerhard Stemmler · 2014 · Psychophysiology
  89. COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials
    Kathryn Tayo Hall, Julie E. Buring, Kenneth Jay Mukamal, M. Vinayaga Moorthy, Peter M. Wayne, Ted Jack Kaptchuk, Elisabeth M. Battinelli, Paul M. Ridker, Howard D. Sesso, Stephanie J. Weinstein et al. · 2018 · JNCI Journal of the National Cancer Institute
  90. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis
    Pradeep Kumar, Vandana Rai · 2019 · Metabolic Brain Disease
  91. Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates
    R. Robinson, Sean M. Smith, Scott E. Wolkenberg, Monika Kandebo, Lihang Yao, Christopher R. Gibson, Scott T. Harrison, Stacey L. Polsky-Fisher, James C. Barrow, Peter J. Manley et al. · 2011 · ACS Chemical Neuroscience
  92. Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis
    Lotti Tajouri, Virginie Martin, Claudia Gasparini, Micky Ovcaric, Robert P. Curtain, Rod A. Lea, Larisa Margaret Haupt, Peter A. Csurhes, Michael P. Pender, Lyn Robyn Griffiths · 2006 · Brain Research Bulletin
  93. Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer
    Yuichiro Tanaka, Masahiro Sasaki, Hiroaki Shiina, Takashi Tokizane, Masao Deguchi, Hiroshi Hirata, Yuji Hinoda, Naoko Okayama, Yutaka Suehiro, Shinji Urakami et al. · 2006 · Cancer Epidemiology Biomarkers & Prevention
  94. An association study of DRD2 and COMT polymorphisms with novelty seeking and harm avoidance scores, in two independent samples of depressed patients.
    Katrina J. Light, Peter R. Joyce, Suzanne E. Luty, Roger Mulder, Janet D. Carter, Christopher Ma Frampton, Allison L. Miller, Martin Alexander Kennedy · 2007 · Behavioral and Brain Functions
  95. Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents
    Walder, Deborah J., Trotman, Hanan D., Cubells, Joseph F., Brasfield, Joy, Tang, Yi-Lang, Walker, Elaine F. · 2010 · Psychiatric Genetics
  96. BDNF rs 6265 polymorphism and COMT rs 4680 polymorphism in deficit schizophrenia in Polish sample
    Justyna Pełka-Wysiecka, Michał Wroński, A Jasiewicz, Anna Grzywacz, Piotr Tybura, Jolanta Kucharska–Mazur, Przemysław Bieńkowski, Jerzy Samochowiec · 2013 · Pharmacological Reports
  97. CatecholO-Methyltransferase (COMT)VAL158METFunctional Polymorphism, Dental Mercury Exposure, and Self-Reported Symptoms and Mood
    Nicholas J. Heyer, Diana Echeverria, Michael D. Martin · 2009 · Journal of Toxicology and Environmental Health
  98. Analysis of Oxidative Stress Status, Catalase and Catechol-O-Methyltransferase Polymorphisms in Egyptian Vitiligo Patients
    Dina Ahmed Mehaney, Hebatallah A. Darwish, Rehab Aly Hegazy, Mohammed Mostafa Nooh, Amira M. El Tawdy, Heba Ismail Gawdat, Maha M. El‐Sawalhi · 2014 · PLoS ONE
  99. Association between polymorphisms in catechol‐O‐methyltransferase (COMT) and cocaine‐induced paranoia in European‐American and African‐American populations
    Rungnapa Ittiwut, Jennifer B. Listman, Chupong Ittiwut, Joseph F. Cubells, Roger D. Weiss, Kathleen T. Brady, David W. Oslin, Lindsay A. Farrer, Henry R. Kranzler, Joel E. Gelernter · 2011 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  100. Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome
    Simon R. O. Nilsson, Kim Fejgin, François Gastambide, Miriam Annika Vogt, Brianne A. Kent, Vibeke Nielsen, Jacob Nielsen, Peter Gass, Trevor William Robbins, Lisa M. Saksida et al. · 2016 · Cerebral Cortex